Cradle

Artificial Intelligence (AI)

Cradle, a biotech enterprise, utilizes AI and predictive algorithms to aid biologists in protein design, streamlining and improving the accuracy of their work in this innovative and critical scientific area.

Cradle, a biotech enterprise, utilizes AI and predictive algorithms to aid biologists in protein design, streamlining and improving the accuracy of their work in this innovative and critical scientific area.

Cradle, a biotech enterprise, utilizes AI and predictive algorithms to aid biologists in protein design, streamlining and improving the accuracy of their work in this innovative and critical scientific area.

Fundings

Fundings

Fundings

Last funding amount

$24M

Last funding amount

$24M

Last funding amount

$24M

Round type

Series A

Round type

Series A

Round type

Series A

Last round date

28, Nov 2023

Last round date

28, Nov 2023

Last round date

28, Nov 2023

Funding total amount

$29.7M

Funding total amount

$29.7M

Funding total amount

$29.7M

Company details

Company details

Company details

Estimated yearly revenue

$2M - $3M

Estimated yearly revenue

$2M - $3M

Estimated yearly revenue

$2M - $3M

No. of employees

30-40

No. of employees

30-40

No. of employees

30-40

Founded date

2021

Founded date

2021

Founded date

2021

Location

Location

Location

Cooperation probability signal

Cooperation probability signal

Cooperation probability signal

how do we calculate it?

50/100

Next Client Score

Company growth

Market trends alignment

Job openings

Innovation score

Industry experience

Financial growth potential

Company reputation

Target audience size

Technical challenges you can help with

Technical challenges you can help with

Technical challenges you can help with

this section is most appreciated by our users

this section is most appreciated by our users

Product challenges you can help with

Product challenges you can help with

Product challenges you can help with

this section is most appreciated by our users

this section is most appreciated by our users

Ideas and innovations you can propose

Ideas and innovations you can propose

Ideas and innovations you can propose

this section is most appreciated by our users

this section is most appreciated by our users

Competitor's solutions you can offer

Competitor's solutions you can offer

Competitor's solutions you can offer

Broadening Therapeutic Applications

Following Be Biopharma's example, Cradle could explore expanding its AI algorithms to design proteins for a wider range of diseases, including those in oncology, autoimmune, and infectious diseases.

Enhanced Software Solutions

Inspired by Molecule.one, Cradle can develop more advanced and specialized software solutions that cater to the unique needs of researchers and chemists, particularly in the area of synthetic biology.

User Interface and Experience

Learning from Genome Compiler, there's an opportunity for Cradle to enhance its software's user interface and experience, making it more intuitive and accessible for biologists and researchers who may not have extensive computational backgrounds.

Data Management and Visualization Tools

Given the complex nature of protein design and the vast amount of data involved, Cradle could benefit from integrating more robust data management and visualization tools, similar to those offered by Genome Compiler.

We have prepared the above solutions based on competitor analysis

Contacts

Contacts

Contacts

Correct data will be available in the full version

Stef Grieken

Co-Founder & CEO

Luba Protopopova

Chief Operating Officer

Daniel Danciu

CTO

Jelle Prins

Co-Founder

Technologies

Technologies

Next.js

React

Google Cloud DNS

Framer

Sentry

Check more companies

Check more companies